DRIZALMA SPRINKLE
Live / Applied — Fourth extension granted (statement of use) (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 03 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97779623
- Mark type
- Design + words
- Filed
- 03 Feb 2023
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurologic disorders, disorders of the nervous system, mental illness, major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain
Owner
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
- Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN
Prior registrations
Prosecution history
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 4 GRANTED
- 19 Nov 2025 — SOU EXTENSION 4 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 21 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 3 GRANTED
- 20 May 2025 — SOU EXTENSION 3 FILED
- 20 May 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2025 — SOU EXTENSION 2 GRANTED
- 15 Nov 2024 — SOU EXTENSION 2 FILED
- 22 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 08 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2024 — SOU EXTENSION 1 GRANTED